Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- Check5 days agoChange DetectedRevision history updated: a new entry v3.4.3 was added and the entry for v3.4.2 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRecord history shows a new revision v3.4.2 added and an older revision v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision history shows a new entry, v3.4.1, and removal of v3.4.0, indicating a minor update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedUI updates include a glossary display, color-coded change highlights, and the revision label v3.4.0, while 'No FEAR Act data' and the previous revision label v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedA new revision version (v3.3.4) was added to the history and the previous revision (v3.3.3) was removed.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History, and the 'HHS Vulnerability Disclosure' item as well as the previous 'Revision: v3.3.2' entry were removed from the page footer.SummaryDifference0.2%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.